As U.S. stocks coasted to the close of their latest winning week, stocks on our local list were no different.

Much of the rest of Wall Street was relatively quiet, and on our list, 12 stocks made positive gains, but most were modest. Of the gainers, Target was the leader at only 1.9%.

Sarepta Therapeutics jumped 30.1% after U.S. regulators approved the use of its medicine for children with Duchenne muscular dystrophy who are at least 4.